Clinical Trials Directory

Trials / Completed

CompletedNCT04346992

Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Fayoum University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease

Detailed description

Aim of the work We aim to examine the prevalence of KC among patients already diagnosed by endocrinologist with TGD. Materials and methods Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using: VA Refraction K reading Slit lamp examination Pentacam Study design Epidemiological study Inclusion citeria All patients diagnosed as thyroid gland dysfunction Control group Exclusion criteria Uncooperative patients

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention

Timeline

Start date
2020-04-12
Primary completion
2022-03-15
Completion
2022-03-15
First posted
2020-04-15
Last updated
2022-09-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04346992. Inclusion in this directory is not an endorsement.